TeorellT.: Kinetics of Distribution of Substances Administered to the Body I. The Extravascular Modes of Administration, Arch. Intern. Pharmacodyn.57: 205–225, 1937.
2.
TeorellT.: Kinetics of Distribution of Substances Administered to the Body II. The Intravascular Modes of Administration, Arch. Intern. Pharmacodyn.57: 226–240, 1937.
3.
WidmarkE., and TandbergJ.: Uber die Bedingungen für die Akkumulation indifferenter Narkotika. Theoretische Berechwingen, Biochem. Z.147: 358–369, 1924.
4.
WagnerJ. G.: Pharmacokinetics, Ann. Rev. Pharmacol.8: 67–94, 1968 (a).
5.
WagnerJ. G.: Pharmacokinetics 1. Definitions, Modeling and Reasons for Measuring Blood Levels and Urinary Excretion, Drug Intelligence2: 38–42, 1968 (b).
6.
BermanM., and SchoenfeldR.: Invariants in Experimental Data on Linear Kinetics and the Formulation of Models, J. Appl. Physics27: 1361–1370, 1956.
7.
HazelrigJane B.: The Impact of High-Speed Automated Computation on Mathematical Models, Proc. Mayo Clinic39: 841–848, 1964.
8.
WagnerJ. G., NorthamJ. I., AlwayC. D., and CarpenterO. S.: Blood Levels of Drug at the Equilibrium State After Multiple Dosing, Nature207: 1301–1302, 1965.
9.
WagnerJ. G.: Drug Accumulation, J. Clin. Pharmacol. J. New Drugs7: 84–88, 1967.
10.
NorthamJ. I., and WagnerJ. G.: “Prediction of Numbers of Doses to Reach Equilibrium State,” presented Basic Pharmaceutics Section, A.Ph.A. Academy of Pharmaceutical Sciences, Miami Beach, Florida, May 5–10, 1968.
11.
Van RossumJ. M., and TomeyA. H. M.: Rate of Accumulation and Plateau Plasma Concentration of Drugs After Chronic Administration, J. Pharm. Pharmacol.20: 390–392, 1968 (a).
12.
Van RossumJ. M.: Pharmacokinetics of Accumulation, J. Pharm. Sci.57: 2162–2165, 1968 (b).
13.
BoxerG. E., JelinekV. C., TompsettR., DuBoisR., and EdisonA. O.: Streptomycin in Blood: Chemical Determinations After Single and Repeated Intramuscular Injections, J. Pharm. Exptl. Therap.92: 226–235, 1948.
14.
SwintoskyJ. V.: Illustrations and Pharmaceutical Interpretations of First Order Drug Elimination Rate from the Bloodstream, J. Am. Pharm. Assoc. Sci. Ed.45: 395–400, 1956.
15.
SwintoskyJ. V., BondiA.Jr., and RobinsonM. J.: Sulfaethylthiadiazole IV. Steady State Blood Concentrations and Urinary Excretion Data Following Repeated Oral Doses, J. Am. Pharm. Assoc. Set. Ed.47: 753–756, 1958.
16.
Von WittenauM. S., and YearyR.: The Excretion and Distribution in Body Fluids of Tetracyclines After Intravenous Administration to Dogs, J. Pharmacol Exptl. Therap.140: 258–266, 1963.
17.
SmithD. L., WagnerJ. G., and GerritsenG. C.: Absorption, Metabolism, and Excretion of 5–Methylpyrazole-3–Carboxylic Acid in the Rat, Dog and Human, J. Pharm. Sci.56: 1150–1157, 1967.
18.
WagnerJ. G.: Pharmacokinetics 8. Construction of Percent Absorbed-Time Plots Based on the Two Compartment Open Model, Drug Intelligence3: 82–97 (Mar.) 1969.
19.
DaytonD. G., CucinellS. A., WeissM., and PerelJ. M.: Dose Dependence of Drug Plasma Level Decline in Dogs, J. Pharmacol. Exptl. Therap.158: 305–316, 1967.
20.
WagnerJ. G.: Pharmacokinetics 3. Half-Life and Volume of Distribution, Drug Intelligence2: 126–133, 1968 (c).
21.
HammerW. M., and BrodieB. B.: Application of Isotope Derivative Technique to Assay of Secondary Amines: Estimation of Desipramine by Acetylation with H3-Acetic Anhydride, J. Pharmacol. Exptl. Therap.157: 503–508, 1967.
22.
Krüger-ThiemerE.: Funktionale Beziehungen Zwischen Den Pharmacokokinetischen Eigenschaften und der Dosierung Von Chemotherapeutica, Klin-Wochenscrift38: 514–520, 1960.
23.
Krüger-ThiemerE.: “Cause and Prevention of Drug Accumulation,” paper presented to the Scientific Section of the American Pharmaceutical Association, Las Vegas, Nevada, March 26–29, 1962.